Mark Lerner
Direttore/Membro del Consiglio presso Gliknik, Inc.
Profilo
Mark David Lerner is the founder of Chesapeake Partners Management Co., Inc. which was founded in 1991.
He held the title of Vice President.
Currently, he is a Non-Executive Director at Gliknik, Inc. since 2014.
Mr. Lerner has an undergraduate degree from the University of Pennsylvania and The Wharton School of the University of Pennsylvania.
Posizioni attive di Mark Lerner
| Società | Posizione | Inizio |
|---|---|---|
Gliknik, Inc.
 Gliknik, Inc. Pharmaceuticals: MajorHealth Technology Gliknik, Inc. discovers and develops biotechnology drugs for autoimmune diseases and cancer. The company was founded by David S. Block and Scott E. Strome in 2007 and is headquartered in Baltimore, MD. | Direttore/Membro del Consiglio | 19/02/2014 |
Precedenti posizioni note di Mark Lerner
| Società | Posizione | Fine |
|---|---|---|
Chesapeake Partners Management Co., Inc.
 Chesapeake Partners Management Co., Inc. Investment ManagersFinance Founded in 1991, Chesapeake Partners Management Co., Inc. is a hedge fund manager located in Baltimore, Maryland. The firm manages the Chesapeake Partners Funds. Investors in the funds include high net-worth individuals and families; pension and profit-sharing plans; trusts, estates or charitable or religious organizations and other corporations or business entities. | Fondatore | - |
Formazione di Mark Lerner
| University of Pennsylvania | Undergraduate Degree |
| The Wharton School of the University of Pennsylvania | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 2 |
|---|---|
Chesapeake Partners Management Co., Inc.
Chesapeake Partners Management Co., Inc. Investment ManagersFinance Founded in 1991, Chesapeake Partners Management Co., Inc. is a hedge fund manager located in Baltimore, Maryland. The firm manages the Chesapeake Partners Funds. Investors in the funds include high net-worth individuals and families; pension and profit-sharing plans; trusts, estates or charitable or religious organizations and other corporations or business entities. | Finance |
Gliknik, Inc.
Gliknik, Inc. Pharmaceuticals: MajorHealth Technology Gliknik, Inc. discovers and develops biotechnology drugs for autoimmune diseases and cancer. The company was founded by David S. Block and Scott E. Strome in 2007 and is headquartered in Baltimore, MD. | Health Technology |
- Borsa valori
- Insiders
- Mark Lerner
